This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Resolutions Of The Annual General Meeting Of Evotec AG

  • Actions of Management Board and Supervisory Board approved
  • Dr Walter Wenninger becomes new Chairman of the Supervisory Board
  • Dr Claus Braestrup elected as new member of the Supervisory Board
  • Fixed remuneration for the Supervisory Board concluded

HAMBURG, Germany, June 12, 2013 (GLOBE NEWSWIRE) -- Shareholders of Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today approved the actions of the members of the Management Board and the Supervisory Board for the fiscal year 2012 at the Annual General Meeting.

The Chief Executive Officer of Evotec AG, Dr Werner Lanthaler, presented the Company's performance for the year 2012 and provided the shareholders with an update on the topic innovation efficiency within Action Plan 2016.

Furthermore, the Annual General Meeting elected Dr Claus Braestrup as new member of the Supervisory Board. Dr Braestrup has extensive experience in executive-level functions at international pharmaceutical companies – among others as former President and CEO and Head of Research and Development of Lundbeck A/S and as Vice President for pharmaceutical research at Novo Nordisk A/S. His special skills in the area of drug research are of great value for his task within the Supervisory Board.

Dr Braestrup succeeds Dr Flemming Ørnskov until the completion of the Annual General Meeting 2014. Dr Ørnskov resigned as member and Chairman of the Supervisory Board upon conclusion of the Annual General Meeting 2013. In a subsequent meeting of the Supervisory Board, Dr Walter Wenninger, former Deputy Chairman of the Supervisory Board, was elected as Chairman of the Supervisory Board and Mr Roland Oetker was elected as his Deputy Chairman.

"I'd like to express my sincere gratitude to Dr Ørnskov, also on behalf of my colleagues in the Management Board, for his constructive and successful collaboration over the last years. We wish him all the best for realising his professional and personal objectives", said Dr Werner Lanthaler, Chief Executive Officer of Evotec. "At the same time, I'd like to warmly welcome Dr Claus Braestrup to the Evotec Supervisory Board."

The Annual General Meeting also approved the proposal of the Management Board and the Supervisory Board to change the remuneration of the Supervisory Board to a fixed remuneration in form of cash compensation from fiscal year 2013 onwards. Moreover, the Annual General Meeting passed all of the other agenda items requiring shareholders' approval, thereunder the resolution on single amendments of the articles of association and the appointment of KPMG as the auditor for fiscal year 2013.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs